Medicare Pay Policy on Transplant Drugs Slammed MedPage Today "Failing to pay for ongoing immunosuppression ensures that Medicare's initial investment in kidney transplantation is squandered, that patients die prematurely, and that US taxpayers pay for a more expensive but inferior therapy after some transplants ... |
